Tobin Scientific Acquires BioRepository Resources

CellBio Scientific Acquires BioChain

May 1, 2025

Biotechnology

CellBio Scientific, a provider of life science tools and research services, has acquired BioChain, a biospecimen collection, preparation, and analysis company based in Newark, California. The acquisition expands CellBio Scientific's capabilities in spatial genomics and biospecimen workflows, consolidating BioChain with System Biosciences and Acepix Biosciences to create a broader translational research platform.

Ott Scientific Acquires American Bionostica

April 1, 2021

Medical Devices

Ott Scientific has acquired American Bionostica, Inc., a developer and manufacturer of specialty lateral flow assays; the acquisition was effective April 1 and ABI will operate inside Ott Scientific’s Ethos Biosciences subsidiary. The American Bionostica team will join Ott Scientific, with expanded research and production capacity planned at Ott Scientific’s new ISO13485/cGMP space in Logan Township, New Jersey.

Limerston Capital Acquires Source BioScience's Stability Storage Business to Form Astoriom

January 15, 2023

Healthcare Services

Limerston Capital has acquired Source BioScience's Stability Storage business (renamed Astoriom) from Source BioScience. The UK-headquartered biorepository specialist, based in Rochdale with 33 employees, will be developed as a platform for buy-and-build expansion into the US and European pharmaceutical and biologics markets.

1315 Capital Acquires SciSafe from BioLife Solutions

November 14, 2024

Healthcare Services

1315 Capital, a Philadelphia-based growth equity firm, has acquired SciSafe from BioLife Solutions in an all-cash transaction that establishes SciSafe as an independent, standalone biostorage company. The deal accompanies a growth capital investment to fund expansion of SciSafe's biostorage, cold-chain and compliance capabilities and to support global footprint growth.

Bruker Corporation Acquires biocrates life sciences ag

June 3, 2025

Biotechnology

Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.

Labcorp Acquires Certain BioReference Health Laboratory Assets for $237.5M

March 28, 2024

Healthcare Services

Labcorp will acquire certain laboratory testing businesses and operating assets from Opko Health subsidiary BioReference Health for $237.5 million. The assets — which generate roughly $100 million in annual revenue — include patient service centers and select customer contracts across the U.S. (excluding New York and New Jersey); BioReference Health will retain its oncology and urology diagnostic businesses and full operations in New York and New Jersey. The transaction is expected to close in the second half of 2024, subject to customary conditions and regulatory approvals.